Llwytho...
Vedolizumab for the Treatment of Moderately to Severely Active Ulcerative Colitis
Ulcerative colitis is a chronic, idiopathic, inflammatory bowel disease characterized by a relapsing and remitting course. A substantial proportion of patients fail conventional therapies despite therapy with immunosuppressives and tumor necrosis factor antagonists. Accordingly, newer therapeutic ag...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Pharmacotherapy |
|---|---|
| Prif Awduron: | , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6709861/ https://ncbi.nlm.nih.gov/pubmed/25884529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1561 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|